Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Through the use of high doses of radiation to kill cancer cells and shrink tumors is achieved by radiation therapy. It is also referred as Radiation Therapy and Irradiation. It involve use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources. Radiotherapy uses radioactive substances that has ability to travels in the blood to tissues throughout the body. Radiotherapy can be referred as local treatment. The radiation therapy works by damaging the DNA of cancerous cells.
The factors that driving the Europe radiotherapy market growth are rising awareness and increasing adoption of radiotherapy devices and procedures as well as technological advancements in radiotherapy devices. Likewise, growing number of cancer patients in overall region will causes growing radiotherapy centers will boosts the market growth in upcoming years. The growing awareness about benefits and recovery of cancerous patients will fuel market growth. Nevertheless, lack of adequate healthcare infrastructure and limiting the number of radiotherapy procedures are the major restraining factor that could hamper the growth of the market.
The COVID 19 outbreak had significant impact on the healthcare market. As the rise in COVID 19 cases, for prevention purpose government has announced lockdown in many countries which lead to postponing of radiotherapy procedures which will affect radiotherapy market. Due to closed manufacturing facilities it will disrupted the supply and production chains. The number of emerging patients towards radiotherapy emergency services which is available in almost all centers are reduced. Due to this scenario, COVID 19 negatively impacted the growth of the overall radiotherapy devices market in 2020.
The study analyses Europe radiotherapy market based on product, application, procedure, end users and country.
Depending on the product the radiotherapy market is bifurcated into external beam radiotherapy, internal beam radiotherapy/brachytherapy and systemic radiotherapy. The external beam radiotherapy is sub-segmented into conventional linear accelerators (LINAC), conventional cobalt-60 teletherapy units, and stereotactic advanced electron and particle therapy systems. The internal beam radiography is sub-segmented into seeds, afterloaders, applicators and IORT Systems. The conventional linear accelerators (LINAC) segment dominated the external beam radiotherapy market in 2020. This LINAC systems use high-energy radiofrequency electromagnetic waves to amplify the velocity of charged subatomic particles to high energies in a linear path.
Based on the application the radiotherapy market is classified into the external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer and Colorectal Cancer. The internal beam radiotherapy/brachytherapy applications market is segmented into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers. The breast cancer segment dominated the market in 2020 and is expected to maintain its dominance during the forecast period 2021-2027 because of, it delivers a precise, highly concentrated radiation dose to the target tumor within less treatment time. Likewise, growing breast cancer cases has increased will impede market growth.
The various procedures used in the radiotherapy market are classified into external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Image-guided Radiotherapy, Intensity-modulated Radiotherapy, Stereotactic Therapy, Particle Therapy and 3D Conformal Radiotherapy. The image guided radiotherapy (IGRT) segment leads the market in 2020 and is witnessing fastest growth in upcoming years. Due to application in radiation oncologists while killing cancerous cells market shows growth.
The various end users include in the radiotherapy market is categorized into Hospitals and independent radiotherapy centers. The hospitals segment is likely to witness the largest market growth in the coming years. The factors driving market growth are rise in prevalence of cancer will causes establishment of new private hospitals for diagnosis and treatment purpose. Besides this, improving healthcare infrastructure will fuel the market growth.
Country wise, the study is comprised of the key countries such as the UK, Germany, France, Italy, Spain and Rest of Europe. The UK held the largest market share of Europe radiotherapy market and is likely to dominate the market over the estimated time frame. Owing to the factors responsible for the market growth in UK are rise in prevalence of cancer and advancement in radiotherapy.
The major key players of market includes Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel),ViewRay, Inc. (US) and ZEISS Group (Germany)
November 2020: Elekta AB (Sweden) received CE mark for the Elekta Harmony linear accelerator, clearing the technology for commercial sales in Europe.
April 2020: Elekta AB (Sweden) launched Geneva, the first universal gynecological applicator for brachytherapy. Geneva applicator is CE-marked and has received US FDA 510(k) clearance. It is used for cervical cancer up to stage IIB.
June 2020: Accuray Incorporated (US) launched the CyberKnife S7 System, an innovative device combining speed, advanced precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
The study analyses Europe radiotherapy market product, application, procedure, end users and country. Radiotherapy plays key role in treating cancer by radiating the tumor cells and destructing its growth and division procedure. The primary growth factors behind the market growth are technological advancements and expansion of the target patient population. The application areas in radiotherapy market are prostate cancer, breast cancer, lung cancer, head and neck Cancer and colorectal cancer. Besides this, increasing applications of radiotherapy and increasing R&D funding for pharma and biotech companies will boosts the market growth. Improving healthcare infrastructure in many regions will drive radiotherapy market growth in upcoming years. The rise in adoption of radiotherapy products in all over the population is expected to impede market growth over the forecast period 2021-2027. The country wise study comprises countries like UK, Germany, France, Italy and rest of Europe. The UK held the largest market share of Europe radiotherapy market and is likely to dominate the market over the estimated time frame.
Why to buy this report:
